97 related articles for article (PubMed ID: 9128383)
1. [A novel assay for detecting the thrombomodulin-protein C/S anticoagulant pathway using human thrombomodulin (prothrombinase assay)].
Mohri M; Sata M; Gomi K; Maruyama Y; Osame M; Maruyama I
Rinsho Byori; 1997 Feb; Suppl 104():203-4. PubMed ID: 9128383
[No Abstract] [Full Text] [Related]
2. Protein C, protein S, and thrombomodulin in amniotic fluid. A preliminary study.
Uszyński M; Zekanowska E; Kotzbach M; Uszyński W; Kotzbach R
J Perinat Med; 2006; 34(4):289-92. PubMed ID: 16856817
[TBL] [Abstract][Full Text] [Related]
3. [Clinical usefulness of global assays of the anticoagulant pathway of protein C].
Toulon P
Ann Biol Clin (Paris); 2001; 59(5):545-50. PubMed ID: 11602384
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of protein S, protein C, and factor X: effects of sex, hormonal state and age.
Henkens CM; Bom VJ; Van der Schaaf W; Pelsma PM; Sibinga CT; de Kam PJ; van der Meer J
Thromb Haemost; 1995 Nov; 74(5):1271-5. PubMed ID: 8607108
[TBL] [Abstract][Full Text] [Related]
5. Further evidence that activated protein C resistance affects protein C coagulant activity assays.
Jennings I; Kitchen S; Cooper PC; Rimmer JE; Woods TA; Preston FE
Thromb Haemost; 2000 Jan; 83(1):171-2. PubMed ID: 10669173
[No Abstract] [Full Text] [Related]
6. Regulation of prothrombinase activity by protein S.
van 't Veer C; Butenas S; Golden NJ; Mann KG
Thromb Haemost; 1999 Jul; 82(1):80-7. PubMed ID: 10456458
[TBL] [Abstract][Full Text] [Related]
7. Increased prothrombinase binding sites in unstimulated platelets from a protein C deficient patient.
Scully MF; Ellis V; Melissari E; Kakkar VV
Thromb Haemost; 1984 Jul; 51(3):407. PubMed ID: 6548586
[No Abstract] [Full Text] [Related]
8. Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
Mahieu B; Jacobs N; Mahieu S; Naelaerts K; Vertessen F; Weyler J; Jacquemyn Y; Van der Planken M
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957
[TBL] [Abstract][Full Text] [Related]
9. Effect of phosphatidylcholine, phosphatidylethanolamine and lysophosphatidylcholine on the protein C/protein S anticoagulation system.
Tsuda T; Yoshimura H; Hamasaki N
Blood Coagul Fibrinolysis; 2006 Sep; 17(6):453-8. PubMed ID: 16905948
[TBL] [Abstract][Full Text] [Related]
10. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
11. Protein S and protein C measurements should not be undertaken during vitamin K antagonist therapy.
Vinholt PJ; Nybo M
Clin Chem Lab Med; 2013 Feb; 51(2):e5-7. PubMed ID: 23096017
[No Abstract] [Full Text] [Related]
12. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
13. Quantitative features of the structure, function and modulation of prothrombinase.
Nesheim ME
Surv Synth Pathol Res; 1984; 3(3):219-32. PubMed ID: 6387851
[No Abstract] [Full Text] [Related]
14. Detecting APC-resistant factor V: a functional method without plasma dilution.
Rylatt DB; Hohnen-Behrens C; Pilgrim RL; Dickeson LE; Neal M; Exner T
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):359-66. PubMed ID: 10493217
[TBL] [Abstract][Full Text] [Related]
15. Defects in natural anticoagulant pathways as potential risk factors for myocardial infarction.
Esmon CT
Circulation; 1997 Jul; 96(1):9-11. PubMed ID: 9236406
[No Abstract] [Full Text] [Related]
16. Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system.
Shen L; He X; Dahlbäck B
Thromb Haemost; 1997 Sep; 78(3):1030-6. PubMed ID: 9308749
[TBL] [Abstract][Full Text] [Related]
17. Specificity of an assay based on a factor V-depleted plasma in patients carrying the Arg 506 Gln mutation.
Alhenc-Gelas M; Aillaud MF; Bonvarlet MN; Dupuy G; Juhan-Vague I; Aiach M
Thromb Haemost; 1996 Jun; 75(6):976-7. PubMed ID: 8822599
[No Abstract] [Full Text] [Related]
18. Evaluation of smoking as a risk factor for activated protein C resistance during pregnancy.
Kafkas S; Kalkan U; Bolaman Z; Sanci M; Yüksel H; Odabaşi AR
Gynecol Obstet Invest; 2007; 64(2):89-94. PubMed ID: 17314487
[TBL] [Abstract][Full Text] [Related]
19. Cardiolipin enhances protein C pathway anticoagulant activity.
Fernández JA; Kojima K; Petäjä J; Hackeng TM; Griffin JH
Blood Cells Mol Dis; 2000 Apr; 26(2):115-23. PubMed ID: 10753602
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mouse models of venous thrombosis: fulfilling the expectations?
Cleuren AC; van Vlijmen BJ; Reitsma PH
Semin Thromb Hemost; 2007 Sep; 33(6):610-6. PubMed ID: 17768694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
